Fig. 2From: 44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigationsStability of 44Sc-DOTA-RGD (a), 44Sc-NODAGA-RGD (b), 68Ga-DOTA-RGD (c), 68Ga-NODAGA-RGD (d), 44Sc-DOTA-NOC (e), 44Sc-NODAGA-NOC (f), 68Ga-DOTA-NOC (g), 68Ga-NODAGA-NOC (h) in saline with and without the presence of 10 mM Cu2+ and Fe3+, respectivelyBack to article page